The global market for Pneumonia Therapeutics was valued at US$ 13650 million in the year 2024 and is projected to reach a revised size of US$ 21370 million by 2031, growing at a CAGR of 6.7% during the forecast period.

Pneumonia Therapeutics Market

Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection.

The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years.

This report aims to provide a comprehensive presentation of the global market for Pneumonia Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumonia Therapeutics.

The Pneumonia Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumonia Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pneumonia Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pneumonia Therapeutics Market Report

Report Metric	Details
Report Name	Pneumonia Therapeutics Market
Accounted market size in year	US$ 13650 million
Forecasted market size in 2031	US$ 21370 million
CAGR	6.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Vaccines Anti-Infectives Oxygen Therapy
Segment by Application	Hospital Clinic Medical Center Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Merck Sharp & Dohme, Novartis, Pfizer, AstraZeneca, Bayer, Biotest, Tetraphase Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pneumonia Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pneumonia Therapeutics Market growing?

Ans: The Pneumonia Therapeutics Market witnessing a CAGR of 6.7% during the forecast period 2025-2031.

What is the Pneumonia Therapeutics Market size in 2031?

Ans: The Pneumonia Therapeutics Market size in 2031 will be US$ 21370 million.

Who are the main players in the Pneumonia Therapeutics Market report?

Ans: The main players in the Pneumonia Therapeutics Market are GlaxoSmithKline, Merck Sharp & Dohme, Novartis, Pfizer, AstraZeneca, Bayer, Biotest, Tetraphase Pharmaceuticals

What are the Application segmentation covered in the Pneumonia Therapeutics Market report?

Ans: The Applications covered in the Pneumonia Therapeutics Market report are Hospital, Clinic, Medical Center, Other

What are the Type segmentation covered in the Pneumonia Therapeutics Market report?

Ans: The Types covered in the Pneumonia Therapeutics Market report are Vaccines, Anti-Infectives, Oxygen Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pneumonia Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Vaccines

1.2.3 Anti-Infectives

1.2.4 Oxygen Therapy

1.3 Market by Application

1.3.1 Global Pneumonia Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Medical Center

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pneumonia Therapeutics Market Perspective (2020-2031)

2.2 Global Pneumonia Therapeutics Growth Trends by Region

2.2.1 Global Pneumonia Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pneumonia Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Pneumonia Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Pneumonia Therapeutics Market Dynamics

2.3.1 Pneumonia Therapeutics Industry Trends

2.3.2 Pneumonia Therapeutics Market Drivers

2.3.3 Pneumonia Therapeutics Market Challenges

2.3.4 Pneumonia Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pneumonia Therapeutics Players by Revenue

3.1.1 Global Top Pneumonia Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Pneumonia Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Pneumonia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pneumonia Therapeutics Revenue

3.4 Global Pneumonia Therapeutics Market Concentration Ratio

3.4.1 Global Pneumonia Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Therapeutics Revenue in 2024

3.5 Global Key Players of Pneumonia Therapeutics Head office and Area Served

3.6 Global Key Players of Pneumonia Therapeutics, Product and Application

3.7 Global Key Players of Pneumonia Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pneumonia Therapeutics Breakdown Data by Type

4.1 Global Pneumonia Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Pneumonia Therapeutics Forecasted Market Size by Type (2026-2031)

5 Pneumonia Therapeutics Breakdown Data by Application

5.1 Global Pneumonia Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Pneumonia Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pneumonia Therapeutics Market Size (2020-2031)

6.2 North America Pneumonia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pneumonia Therapeutics Market Size by Country (2020-2025)

6.4 North America Pneumonia Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pneumonia Therapeutics Market Size (2020-2031)

7.2 Europe Pneumonia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pneumonia Therapeutics Market Size by Country (2020-2025)

7.4 Europe Pneumonia Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pneumonia Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Pneumonia Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pneumonia Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Pneumonia Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pneumonia Therapeutics Market Size (2020-2031)

9.2 Latin America Pneumonia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pneumonia Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Pneumonia Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pneumonia Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Pneumonia Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pneumonia Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Pneumonia Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Details

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Pneumonia Therapeutics Introduction

11.1.4 GlaxoSmithKline Revenue in Pneumonia Therapeutics Business (2020-2025)

11.1.5 GlaxoSmithKline Recent Development

11.2 Merck Sharp & Dohme

11.2.1 Merck Sharp & Dohme Company Details

11.2.2 Merck Sharp & Dohme Business Overview

11.2.3 Merck Sharp & Dohme Pneumonia Therapeutics Introduction

11.2.4 Merck Sharp & Dohme Revenue in Pneumonia Therapeutics Business (2020-2025)

11.2.5 Merck Sharp & Dohme Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Pneumonia Therapeutics Introduction

11.3.4 Novartis Revenue in Pneumonia Therapeutics Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Pneumonia Therapeutics Introduction

11.4.4 Pfizer Revenue in Pneumonia Therapeutics Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 AstraZeneca

11.5.1 AstraZeneca Company Details

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca Pneumonia Therapeutics Introduction

11.5.4 AstraZeneca Revenue in Pneumonia Therapeutics Business (2020-2025)

11.5.5 AstraZeneca Recent Development

11.6 Bayer

11.6.1 Bayer Company Details

11.6.2 Bayer Business Overview

11.6.3 Bayer Pneumonia Therapeutics Introduction

11.6.4 Bayer Revenue in Pneumonia Therapeutics Business (2020-2025)

11.6.5 Bayer Recent Development

11.7 Biotest

11.7.1 Biotest Company Details

11.7.2 Biotest Business Overview

11.7.3 Biotest Pneumonia Therapeutics Introduction

11.7.4 Biotest Revenue in Pneumonia Therapeutics Business (2020-2025)

11.7.5 Biotest Recent Development

11.8 Tetraphase Pharmaceuticals

11.8.1 Tetraphase Pharmaceuticals Company Details

11.8.2 Tetraphase Pharmaceuticals Business Overview

11.8.3 Tetraphase Pharmaceuticals Pneumonia Therapeutics Introduction

11.8.4 Tetraphase Pharmaceuticals Revenue in Pneumonia Therapeutics Business (2020-2025)

11.8.5 Tetraphase Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Tetraphase Pharmaceuticals

List of Tables

Table 1. Global Pneumonia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Vaccines

Table 3. Key Players of Anti-Infectives

Table 4. Key Players of Oxygen Therapy

Table 5. Global Pneumonia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Pneumonia Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Pneumonia Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Pneumonia Therapeutics Market Share by Region (2020-2025)

Table 9. Global Pneumonia Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Pneumonia Therapeutics Market Share by Region (2026-2031)

Table 11. Pneumonia Therapeutics Market Trends

Table 12. Pneumonia Therapeutics Market Drivers

Table 13. Pneumonia Therapeutics Market Challenges

Table 14. Pneumonia Therapeutics Market Restraints

Table 15. Global Pneumonia Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Pneumonia Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top Pneumonia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Therapeutics as of 2024)

Table 18. Ranking of Global Top Pneumonia Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Pneumonia Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Pneumonia Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Pneumonia Therapeutics, Product and Application

Table 22. Global Key Players of Pneumonia Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Pneumonia Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Pneumonia Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global Pneumonia Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Pneumonia Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global Pneumonia Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Pneumonia Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global Pneumonia Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Pneumonia Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America Pneumonia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Pneumonia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Pneumonia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Pneumonia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Pneumonia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Pneumonia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Pneumonia Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Pneumonia Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Pneumonia Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Pneumonia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Pneumonia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Pneumonia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Pneumonia Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Pneumonia Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Pneumonia Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. GlaxoSmithKline Company Details

Table 48. GlaxoSmithKline Business Overview

Table 49. GlaxoSmithKline Pneumonia Therapeutics Product

Table 50. GlaxoSmithKline Revenue in Pneumonia Therapeutics Business (2020-2025) & (US$ Million)

Table 51. GlaxoSmithKline Recent Development

Table 52. Merck Sharp & Dohme Company Details

Table 53. Merck Sharp & Dohme Business Overview

Table 54. Merck Sharp & Dohme Pneumonia Therapeutics Product

Table 55. Merck Sharp & Dohme Revenue in Pneumonia Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Merck Sharp & Dohme Recent Development

Table 57. Novartis Company Details

Table 58. Novartis Business Overview

Table 59. Novartis Pneumonia Therapeutics Product

Table 60. Novartis Revenue in Pneumonia Therapeutics Business (2020-2025) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. Pfizer Company Details

Table 63. Pfizer Business Overview

Table 64. Pfizer Pneumonia Therapeutics Product

Table 65. Pfizer Revenue in Pneumonia Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Pfizer Recent Development

Table 67. AstraZeneca Company Details

Table 68. AstraZeneca Business Overview

Table 69. AstraZeneca Pneumonia Therapeutics Product

Table 70. AstraZeneca Revenue in Pneumonia Therapeutics Business (2020-2025) & (US$ Million)

Table 71. AstraZeneca Recent Development

Table 72. Bayer Company Details

Table 73. Bayer Business Overview

Table 74. Bayer Pneumonia Therapeutics Product

Table 75. Bayer Revenue in Pneumonia Therapeutics Business (2020-2025) & (US$ Million)

Table 76. Bayer Recent Development

Table 77. Biotest Company Details

Table 78. Biotest Business Overview

Table 79. Biotest Pneumonia Therapeutics Product

Table 80. Biotest Revenue in Pneumonia Therapeutics Business (2020-2025) & (US$ Million)

Table 81. Biotest Recent Development

Table 82. Tetraphase Pharmaceuticals Company Details

Table 83. Tetraphase Pharmaceuticals Business Overview

Table 84. Tetraphase Pharmaceuticals Pneumonia Therapeutics Product

Table 85. Tetraphase Pharmaceuticals Revenue in Pneumonia Therapeutics Business (2020-2025) & (US$ Million)

Table 86. Tetraphase Pharmaceuticals Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

Table 90. Authors List of This Report

List of Figures

Figure 1. Pneumonia Therapeutics Picture

Figure 2. Global Pneumonia Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pneumonia Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Vaccines Features

Figure 5. Anti-Infectives Features

Figure 6. Oxygen Therapy Features

Figure 7. Global Pneumonia Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Pneumonia Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Medical Center Case Studies

Figure 12. Other Case Studies

Figure 13. Pneumonia Therapeutics Report Years Considered

Figure 14. Global Pneumonia Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Pneumonia Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Pneumonia Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global Pneumonia Therapeutics Market Share by Players in 2024

Figure 18. Global Top Pneumonia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Therapeutics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Pneumonia Therapeutics Revenue in 2024

Figure 20. North America Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Pneumonia Therapeutics Market Share by Country (2020-2031)

Figure 22. United States Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Pneumonia Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Pneumonia Therapeutics Market Share by Region (2020-2031)

Figure 34. China Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Pneumonia Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Pneumonia Therapeutics Market Share by Country (2020-2031)

Figure 46. Turkey Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Pneumonia Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. GlaxoSmithKline Revenue Growth Rate in Pneumonia Therapeutics Business (2020-2025)

Figure 50. Merck Sharp & Dohme Revenue Growth Rate in Pneumonia Therapeutics Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Pneumonia Therapeutics Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Pneumonia Therapeutics Business (2020-2025)

Figure 53. AstraZeneca Revenue Growth Rate in Pneumonia Therapeutics Business (2020-2025)

Figure 54. Bayer Revenue Growth Rate in Pneumonia Therapeutics Business (2020-2025)

Figure 55. Biotest Revenue Growth Rate in Pneumonia Therapeutics Business (2020-2025)

Figure 56. Tetraphase Pharmaceuticals Revenue Growth Rate in Pneumonia Therapeutics Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Respiratory Disease Treatment Market Research Report 2025

Global Respiratory Drug Market Research Report 2024

Global Interstitial Pneumonia Market Research Report 2024

Global Influenza Therapeutics Market Insights Forecast to 2030

Respiratory Diseases Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Pneumonia Diagnostics Kit Market Research Report 2024

Global Drug Treatment for Respiratory Disease Market Research Report 2024

Viral Pneumonia Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pneumococcal Vaccination Market Research Report 2025

Global Pneumoconiosis Treatment Market Insights Forecast to 2030

Global Legionella Testing Market Research Report 2024

COPD Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Poliomyelitis Therapeutics Market Insights Forecast to 2030

Respiratory Inhaler Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs for Respiratory Diseases Market Research Report 2024

Respiratory Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions